Search

已探明塔里木盆地下古生界碳酸盐岩地层储量巨大。对塔里木盆地西北部柯坪-巴楚-阿图什一带的4 块区域开展了系统的野外和重点观测工作，包括蓬莱坝剖面、柯坪水泥厂剖面、托普郎剖面等。本研究通过考察塔里木盆地奥陶系碳酸盐岩热液溶蚀及相关现象。从野外产状、伴生关系以及矿物岩石学特征角度解剖奥陶系地层中热液矿物组合的地质特征。研究表明，该区域存在富镁流体、富氟流体和富硫流体3 种流体，分别来源于封存卤水、火成活动和TSR 热液。不同性质流体蚀变具有相似的分带性。

Copyright of Polymer Materials Science & Engineering is the property of Sichuan University, Polymer Research Institute and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Rare Metal Materials & Engineering is the property of Northwest Institute for Nonferrous Metal Research and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Zhejiang University (Science Edition) is the property of Journal of Zhejiang University (Science Edition) Editorial Office and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of China Sciencepaper is the property of China Sciencepaper and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective To investigate the effect of carvedilol on the migration, invasion and fibrosis of human hepatic stellate cells, as well as related signaling pathways and mechanisms. MethodsHuman hepatic stellate cell line LX-2 was treated with different concentrations of carvedilol (0, 1, 2, 5, and 10 μmol/L, and platelet-derived growth factor-BB (PDGF-BB) was added to activate the cells. CCK-8 assay was used to measure cell proliferation, wound healing assay was used to measure migration, Transwell chamber assay was used to measure invasion, and Western blot and real-time PCR were used to measure the protein and mRNA expression of fibrosis markers and pathway proteins. The cells were divided into blank control group, PDGF-BB group (only PDGF-BB was added), and four carvedilol groups (with 1, 2, 5, or 10 μmol/L carvedilol, as well as PDGF-BB). A one-way analysis of variance was used for comparison of continuous data between multiple groups, and the Dunnett-t test was used for comparison between experimental groups and control group. ResultsCarvedilol inhibited the proliferation of LX-2 cells in a concentration-dependent manner, with a half-inhibitory concentration of 28.42 μmol/L. Compared with the PDGF-BB group, the 10 μmol/L carvedilol group had significantly inhibited migration of LX-2 cells (59.780%±8.898% vs 17.270%±2.668%, t=4.576, P=0.010). PDGF-BB increased the invasion of LX-2 cells, and carvedilol inhibited the invasion of LX-2 cells in a concentration-dependent manner; the invasion of LX-2 cells was reduced from 157.00%±10.52% to 85.15%±13.50% in the 2 μmol/L carvedilol group (t=4.198, P=0.014), to 55.67%±9.54% in the 5 μmol/L carvedilol group (t=7.133, P＜0.01), and to 45.37%±10.70% in the 10 μmol/L carvedilol group (t=7.438, P＜0.01). The mRNA expression of type I collagen was reduced from 1.068±0.128 to 0.453±0.085 in the 5 μmol/L carvedilol group (t=3.997, P＜0.05) and to 0.151±0.019 in the 10 μmol/L carvedilol group (t=7.091, P＜0.01). The mRNA expression of fibronectin was reduced from 1.285±0.042 to 0.879±0.063 in the 1 μmol/L carvedilol group (t=5.345, P＜0.01), to 0.768±0.010 in the 2 μmol/L carvedilol group (t=4.773, P＜0.01), to 0.742±0.117 in the 5 μmol/L carvedilol group (t=4.385, P=0.012), and to 0.591±0.049 in the 10 μmol/L carvedilol group (t=10.76, P＜0.01). The expression of fibronectin was reduced from 2.103±0.414 to 0.739±0.132 in the 5 μmol/L carvedilol group (t=3.137, P=0.035) and to 0.600±0.114 in the 10 μmol/L carvedilol group (t=3.499, P=0.025), and the expression of α-smooth muscle actin was reduced from 1.418±0.241 to 0.543±0.215 (t=2.710, P=0.035) and 0.343±0.118 (t=4.005, P＜0.01), respectively. Y751 phosphorylation was reduced from 2.309±0.181 to 1.278±0.304 in the 2 μmol/L carvedilol group (t=2.912, P=0.044), to 0.555±0.038 in the 5 μmol/L carvedilol group (t=9.476, P＜0.01), and to 0.175±0.039 in the 10 μmol/L group (t=11.51, P＜0.01). Akt phosphorylation was reduced from 1.106±0.185 to 0.335±0.132 in the 5 μmol/L carvedilol group (t=3.386, P=0.015) and to 0.137±0.110 in the 10 μmol/L carvedilol group (t=4.494, P＜0.01). ConclusionCarvedilol can inhibit the proliferation, migration, invasion, and fibrosis of LX-2 cells induced by PDGF-BB, mainly by blocking the PDGF-BB/PDGFR-β/Akt signaling pathway. [ABSTRACT FROM AUTHOR]